Showing results (1-10 of 326) with videos related to
Sort By:
Pageof 33
Thrombosis Research. Supplement|January 1, 1991
Laboratory monitoring of the clinical effects of low molecular weight heparinsJ M Walenga, D Hoppensteadt, J FareedDrugs & Aging|September 1, 1992
Low molecular weight heparins. An objective overviewD Hoppensteadt, J M Walenga, J FareedThrombosis Research|November 1, 1990
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate and heparinD Hoppensteadt, J M Walenga, J FareedSeminars in Thrombosis and Hemostasis|January 1, 1991
Non-heparin glycosaminoglycan-derived drugs: a biochemical and pharmacologic perspectiveJ M Walenga, D Hoppensteadt, J FareedThe Annals of Thoracic Surgery|May 1, 1992
Hemostatic abnormalities in total artificial heart patients as detected by specific blood markersJ M Walenga, D Hoppensteadt, J Fareed, et al.Seminars in Thrombosis and Hemostasis|October 1, 1983
Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methodsL G Svendsen, J Fareed, J M Walenga, et al.The Medical Clinics of North America|May 1, 1994
Current trends in the development of anticoagulant and antithrombotic drugsJ Fareed, D Hoppensteadt, J M Walenga, et al.Critical Reviews in Clinical Laboratory Sciences|January 1, 1986
In vitro evaluation of heparin fractions: old vs. new methodsJ M Walenga, J Fareed, D Hoppensteadt, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 10, 1998
Molecular markers of hemostatic activation and inflammation following major injury: effect of therapy with IFN-gammaD J Dries, J M Walenga, D Hoppensteadt, et al.Seminars in Thrombosis and Hemostasis|October 1, 1984
Performance characteristics of a simple radioimmunoassay for fibrinopeptide AJ M Walenga, D Hoppensteadt, R M Emanuele, et al.Pageof 33